PL2900269T3 - Połączenie regorafenibu i kwasu acetylosalicylowego do leczenia raka jelita grubego - Google Patents

Połączenie regorafenibu i kwasu acetylosalicylowego do leczenia raka jelita grubego

Info

Publication number: PL2900269T3
Authority: PL; Poland
Prior art keywords: regorafenib; combination; colorectal cancer; acetylsalicylic acid; treating colorectal
Prior art date: 2012-09-25

Application number

PL13770659T

Other languages

English (en)

Inventor

Olaf Weber

Karl Ziegelbauer

Original Assignee

Bayer Pharma Aktiengesellschaft

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-09-25

Filing date

2013-09-23

Publication date

2019-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46963566&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2900269(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-09-23 Application filed by Bayer Pharma Aktiengesellschaft, Bayer Ag filed Critical Bayer Pharma Aktiengesellschaft

2019-02-28 Publication of PL2900269T3 publication Critical patent/PL2900269T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

PL13770659T 2012-09-25 2013-09-23 Połączenie regorafenibu i kwasu acetylosalicylowego do leczenia raka jelita grubego PL2900269T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP12185852		2012-09-25
PCT/EP2013/069735 WO2014048881A1 (en)	2012-09-25	2013-09-23	Combination of regorafenib and acetylsalicylic acid for treating cancer
EP13770659.4A EP2900269B1 (en)	2012-09-25	2013-09-23	Combination of regorafenib and acetylsalicylic acid for treating colorectal cancer

Publications (1)

Publication Number	Publication Date
PL2900269T3 true PL2900269T3 (pl)	2019-02-28

Family

ID=46963566

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13770659T PL2900269T3 (pl)	2012-09-25	2013-09-23	Połączenie regorafenibu i kwasu acetylosalicylowego do leczenia raka jelita grubego

Country Status (29)

Country	Link
US (1)	US10898500B2 (pl)
EP (1)	EP2900269B1 (pl)
JP (1)	JP6294888B2 (pl)
KR (1)	KR102210575B1 (pl)
CN (1)	CN104994876A (pl)
AU (1)	AU2013322854B2 (pl)
BR (1)	BR112015006686B1 (pl)
CA (1)	CA2885688C (pl)
CL (1)	CL2015000744A1 (pl)
CY (1)	CY1120939T1 (pl)
DK (1)	DK2900269T3 (pl)
EA (1)	EA032023B1 (pl)
ES (1)	ES2687985T3 (pl)
HK (1)	HK1214169A1 (pl)
HR (1)	HRP20181462T1 (pl)
HU (1)	HUE039878T2 (pl)
IL (1)	IL237690B (pl)
LT (1)	LT2900269T (pl)
MX (1)	MX357035B (pl)
MY (1)	MY183969A (pl)
NZ (1)	NZ705860A (pl)
PH (1)	PH12015500587A1 (pl)
PL (1)	PL2900269T3 (pl)
PT (1)	PT2900269T (pl)
RS (1)	RS57875B1 (pl)
SG (2)	SG10201702356VA (pl)
SI (1)	SI2900269T1 (pl)
WO (1)	WO2014048881A1 (pl)
ZA (1)	ZA201502840B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG11201407534PA (en)	2012-06-13	2014-12-30	Hoffmann La Roche	New diazaspirocycloalkane and azaspirocycloalkane
IN2015DN00960A (pl)	2012-09-25	2015-06-12	Hoffmann La Roche
AR095079A1 (es)	2013-03-12	2015-09-16	Hoffmann La Roche	Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
MY187449A (en)	2013-11-26	2021-09-22	Hoffmann La Roche	New octahydro-cyclobuta [1,2-c;3,4-c']dipyrrol-2-yl
HUE046820T2 (hu)	2014-03-26	2020-03-30	Hoffmann La Roche	Biciklusos vegyületek autotaxin (ATX) és lizofoszfatidsav (LPA) termelésgátlókként
JP6554481B2 (ja)	2014-03-26	2019-07-31	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	オートタキシン（ａｔｘ）及びリゾホスファチジン酸（ｌｐａ）産生の阻害剤としての縮合［１，４］ジアゼピン化合物
CN103923001B (zh) *	2014-04-30	2016-02-10	药源药物化学（上海）有限公司	瑞戈非尼盐及其晶型、制备方法
MA41898A (fr)	2015-04-10	2018-02-13	Hoffmann La Roche	Dérivés de quinazolinone bicyclique
CR20180058A (es)	2015-09-04	2018-02-26	Hoffmann La Roche	Nuevos derivados de fenoximetilo
CN105267167A (zh) *	2015-09-11	2016-01-27	江苏嘉逸医药有限公司	一种瑞戈非尼口服固体药物组合物的制备方法
MX2017015034A (es)	2015-09-24	2018-04-13	Hoffmann La Roche	Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca).
KR20180054830A (ko)	2015-09-24	2018-05-24	에프. 호프만-라 로슈 아게	오토탁신(atx) 억제제로서의 이환형 화합물
MX2018001890A (es)	2015-09-24	2018-06-20	Hoffmann La Roche	Compuestos biciclicos como inhibidores de autotaxina (atx).
CN107922415B (zh)	2015-09-24	2022-04-15	豪夫迈·罗氏有限公司	新的作为双重atx/ca抑制剂的二环化合物
ES2897981T3 (es) *	2016-06-28	2022-03-03	Asamedic As	Composición de dos componentes que comprende ácido acetilsalicílico
WO2018167113A1 (en)	2017-03-16	2018-09-20	F. Hoffmann-La Roche Ag	New bicyclic compounds as atx inhibitors
CR20190423A (es)	2017-03-16	2019-11-01	Hoffmann La Roche	Nuevos compuestos biciclícos como inhibidores dobles de atx/ca
CA3065125A1 (en) *	2017-06-02	2018-12-06	Bayer Aktiengesellschaft	Combination of regorafenib and pd-1/pd-l1(2) inhibitors for treating cancer
EP3501522A1 (en)	2017-12-22	2019-06-26	Asamedic AS	Compositions comprising acetylsalicylic acid and a phosphate salt
EP3501523A1 (en)	2017-12-22	2019-06-26	Asamedic AS	Two-component compositions comprising acetyl salicylic acid and a carbonate salt
KR20210156389A (ko)	2020-06-17	2021-12-27	재단법인대구경북과학기술원	레고라페닙을 유효성분으로 포함하는 염증질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1197228A4 (en) *	1999-07-02	2004-03-10	Hisamitsu Pharmaceutical Co	DRUG COMPOSITIONS FOR THE TREATMENT OF COLORECTAL CANCER
US20040121004A1 (en) *	2002-12-20	2004-06-24	Rajneesh Taneja	Dosage forms containing a PPI, NSAID, and buffer
UA84156C2 (ru) *	2003-07-23	2008-09-25	Байер Фармасьютикалс Корпорейшн	Фторозамещённая омега-карбоксиарилдифенилмочевина для лечения и профилактики болезней и состояний
WO2007054303A2 (en) *	2005-11-10	2007-05-18	Bayer Healthcare Ag	Diaryl urea for treating diabetic neuropathy
AR062927A1 (es)	2006-10-11	2008-12-17	Bayer Healthcare Ag	4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
GB201002530D0 (en) *	2010-02-15	2010-03-31	Univ Wolverhampton The	Di-aspirin derivatives
AR081060A1 (es)	2010-04-15	2012-06-06	Bayer Schering Pharma Ag	Procedimiento para preparar 4-{4-[({[4-cloro-3-(trifluorometil)fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridin-2-carboxamida

2013
- 2013-09-23 MX MX2015003728A patent/MX357035B/es active IP Right Grant
- 2013-09-23 LT LTEP13770659.4T patent/LT2900269T/lt unknown
- 2013-09-23 DK DK13770659.4T patent/DK2900269T3/en active
- 2013-09-23 PL PL13770659T patent/PL2900269T3/pl unknown
- 2013-09-23 EP EP13770659.4A patent/EP2900269B1/en active Active
- 2013-09-23 RS RS20181015A patent/RS57875B1/sr unknown
- 2013-09-23 JP JP2015532437A patent/JP6294888B2/ja active Active
- 2013-09-23 PT PT13770659T patent/PT2900269T/pt unknown
- 2013-09-23 SG SG10201702356VA patent/SG10201702356VA/en unknown
- 2013-09-23 MY MYPI2015700911A patent/MY183969A/en unknown
- 2013-09-23 NZ NZ705860A patent/NZ705860A/en unknown
- 2013-09-23 HU HUE13770659A patent/HUE039878T2/hu unknown
- 2013-09-23 SG SG11201501963RA patent/SG11201501963RA/en unknown
- 2013-09-23 CN CN201380050150.7A patent/CN104994876A/zh active Pending
- 2013-09-23 ES ES13770659.4T patent/ES2687985T3/es active Active
- 2013-09-23 EA EA201500365A patent/EA032023B1/ru not_active IP Right Cessation
- 2013-09-23 US US14/431,119 patent/US10898500B2/en active Active
- 2013-09-23 AU AU2013322854A patent/AU2013322854B2/en active Active
- 2013-09-23 SI SI201331181T patent/SI2900269T1/sl unknown
- 2013-09-23 CA CA2885688A patent/CA2885688C/en active Active
- 2013-09-23 WO PCT/EP2013/069735 patent/WO2014048881A1/en active Application Filing
- 2013-09-23 BR BR112015006686-0A patent/BR112015006686B1/pt active IP Right Grant
- 2013-09-23 KR KR1020157010519A patent/KR102210575B1/ko active IP Right Grant
2015
- 2015-03-12 IL IL237690A patent/IL237690B/en active IP Right Grant
- 2015-03-17 PH PH12015500587A patent/PH12015500587A1/en unknown
- 2015-03-24 CL CL2015000744A patent/CL2015000744A1/es unknown
- 2015-04-24 ZA ZA2015/02840A patent/ZA201502840B/en unknown
2016
- 2016-03-01 HK HK16102326.3A patent/HK1214169A1/zh unknown
2018
- 2018-09-12 HR HRP20181462TT patent/HRP20181462T1/hr unknown
- 2018-09-20 CY CY181100976T patent/CY1120939T1/el unknown

Also Published As

Publication number	Publication date
EA201500365A1 (ru)	2015-08-31
LT2900269T (lt)	2018-11-12
JP6294888B2 (ja)	2018-03-14
NZ705860A (en)	2018-07-27
US10898500B2 (en)	2021-01-26
ES2687985T3 (es)	2018-10-30
IL237690A0 (en)	2015-05-31
US20150202214A1 (en)	2015-07-23
CA2885688C (en)	2021-03-02
PH12015500587A1 (en)	2015-05-11
CA2885688A1 (en)	2014-04-03
AU2013322854A1 (en)	2015-04-02
EP2900269A1 (en)	2015-08-05
SG11201501963RA (en)	2015-04-29
ZA201502840B (en)	2017-11-29
RS57875B1 (sr)	2018-12-31
SI2900269T1 (sl)	2018-10-30
DK2900269T3 (en)	2018-10-01
MX357035B (es)	2018-06-25
IL237690B (en)	2019-07-31
HRP20181462T1 (hr)	2018-11-02
WO2014048881A1 (en)	2014-04-03
BR112015006686A2 (pt)	2019-08-27
CN104994876A (zh)	2015-10-21
BR112015006686B1 (pt)	2022-04-05
PT2900269T (pt)	2018-10-22
EA032023B1 (ru)	2019-03-29
MY183969A (en)	2021-03-17
SG10201702356VA (en)	2017-04-27
CY1120939T1 (el)	2019-12-11
KR20150060869A (ko)	2015-06-03
HUE039878T2 (hu)	2019-02-28
JP2015529234A (ja)	2015-10-05
KR102210575B1 (ko)	2021-02-02
CL2015000744A1 (es)	2016-01-08
MX2015003728A (es)	2015-09-23
HK1214169A1 (zh)	2016-07-22
AU2013322854B2 (en)	2018-07-19
EP2900269B1 (en)	2018-08-01

Publication	Publication Date	Title
HRP20181462T1 (hr)	2018-11-02	Kombinacija regorafeniba i acetilsalicilne kiseline za liječenje raka debelog crijeva
IL288181A (en)	2022-01-01	Cancer treatment methods
HRP20171474T1 (hr)	2017-11-03	Triazolopirazini kao inhibitori brd4 za uporabu u liječenju raka
HK1209798A1 (en)	2016-04-08	Compositions and methods for treating cancer
EP2818483A4 (en)	2015-09-02	MEDICINAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
EP2836482A4 (en)	2015-12-09	COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
EP2890720A4 (en)	2016-01-13	COMPOSITIONS AND METHODS OF TREATING CANCER
IL238177A0 (en)	2015-05-31	Methods and preparations for the treatment of cancer
EP2688594A4 (en)	2014-07-30	METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
HK1216854A1 (zh)	2016-12-09	用於治療癌症的組合物和方法
EP2928456A4 (en)	2016-08-24	METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2841102A4 (en)	2015-05-06	METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2822593A4 (en)	2015-10-14	COMPOSITIONS AND METHODS FOR TREATING CANCER
EP2902027A4 (en)	2016-06-22	ACTIVE COMPOSITION FOR THE TREATMENT OF TUMORS AND THE USE THEREOF